New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

The effects of dementia can be devastating for both individuals with the disease and their family members. However, detecting ...

When dementia is diagnosed early on, there are more treatment and management options.Dr. Sudha Seshadri — the founding director of the Alzheimer’s and neurodegenerative diseases institute at UT Health ...

Doctors and aging experts say early intervention is key. When dementia is diagnosed early on, there are more treatment and ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Changes like these are alarming and can be the signs of rapidly progressive dementia, a rare type of dementia that causes sudden decline. Read on to learn more about the causes, symptoms and ...

Hugo Fernandes, at the University of Oxford, is working to understand the role of fats and the progression of dementia. Hugo Fernandes, at the University of Oxford, is working to understand the role ...

That's where you've got real potential to slow down disease progression before too much damage is done.' We already know that there are changes in the body's chemistry long before the signs of ...

Alzheimer’s disease is a brain disorder and type of dementia primarily characterized ... Alzheimer’s disease is a chronic, progressive disease, in which symptoms worsen over time.

Yet, despite the increasing need for effective treatments, therapies for age-related dementia have largely failed to slow or halt the disease's progression. Now, a University of Oklahoma ...

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

It happens after three non-REM stages, each progressively deeper ... The study, published on January 27 in Alzheimer’s & Dementia, involved 128 participants from the neurology unit of the ...